Newsroom

Scientists at Cytel recently published a paper in the Journal of the American Medical Association (JAMA). Among the..

Former Commissioner of the FDA, Dr. Scott Gottlieb, in several public presentations, would bemoan missed chances to..

In recent times, Single arm trials are being increasingly used to assess new treatment interventions. They establish..

Recent years have witnessed improving survival outcomes for those struggling with a range of common kidney cancers...

COVID-19 has transformed the pharmaceutical industry in a manner that few could have predicted only a year ago. One of..

Virtual ISPOR 2020, held November 16 to 19, presented new opportunities for scientific interaction amongst HEOR..

  As a part of Cytel’s "New Horizons Webinar Series", Alind Gupta, Senior Data Scientist, presents case studies from..

Cytel and Ingress Health (now a Cytel company) will be contributing to a range of events at Virtual ISPOR EUROPE 2020,..

In oncology, many manufacturers go into niche indications, where there are very specific tumors, and then they opt for..